RM

Raju Madrakolla

Active Director Director DIN 10461277
DIN 10461277 First appointment Jan 2024
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value •••• Premium profile

About Raju Madrakolla

Data last updated:

Raju Madrakolla is a Director at Curehive Pharma Private Limited (since 2024). Curehive Pharma Private Limited reported revenue of ₹49,101 (FY 2025).

DIN 10461277
Primary Designation Director
First Appointment 11 Jan 2024
Oldest Company Age 2 yrs
Largest company Curehive Pharma Private Limited · ₹49,101 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Curehive Pharma Private Limited U46497TS2024PTC180935
Director11 Jan 20242024₹49,101 (FY 2025)Active

Board colleagues of Raju Madrakolla

NameDINCompanyDesignation
Chakrapani Nagashetty10461276Curehive Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Curehive Pharma Private Limited
Premium access

Shareholding and investment profile for Raju Madrakolla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Raju Madrakolla

Raju Madrakolla currently holds 1 directorship: Curehive Pharma Private Limited (Director, since 11 Jan 2024, revenue ₹49,101 (FY 2025)).

Raju Madrakolla was first appointed on 11 Jan 2024 as Director at Curehive Pharma Private Limited.

The current boards of Raju Madrakolla's companies include Chakrapani Nagashetty (Curehive Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available